Watson David Hibbert

SEC source: 0001415889-24-029969 · form4-12202024_041201.xml · nonDerivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,291

F2 · shares: On December 18, 2024, the Reporting Person sold 10,000 shares of common stock on the open market at an average price of $146.05 per share.

SEC source: 0001415889-24-029969 · form4-12202024_041201.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,291

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On December 18, 2024, the Reporting Person exercised his stock option awarded on April 6, 2017 to purchase 40,000 shares of the Issuer's common stock at a price of $64.25 per share, using the net settle method.

SEC source: 0001415889-24-023251 · form4-09112024_100913.xml · derivative · entry 4

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,334

Underlying: Common Stock · 6,666 shares

Expires 2032-04-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On September 10, 2024, the Reporting Person exercised his stock option awarded on April 18, 2022 to purchase 6,666 shares of the Issuer's common stock at a price of $36.78 per share, using the net settle method.

SEC source: 0001415889-24-023251 · form4-09112024_100913.xml · derivative · entry 3

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,000

Underlying: Common Stock · 10,000 shares

Expires 2031-04-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On September 10, 2024, the Reporting Person exercised his stock option awarded on April 16, 2021 to purchase 10,000 shares of the Issuer's common stock at a price of $54.60 per share, using the net settle method.

SEC source: 0001415889-24-023251 · form4-09112024_100913.xml · nonDerivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,789

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On September 10, 2024, the Reporting Person exercised his stock option awarded on April 18, 2022 to purchase 6,666 shares of the Issuer's common stock at a price of $36.78 per share, using the net settle method.

SEC source: 0001415889-24-023251 · form4-09112024_100913.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,589

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On September 10, 2024, the Reporting Person exercised his stock option awarded on April 16, 2021 to purchase 10,000 shares of the Issuer's common stock at a price of $54.60 per share, using the net settle method.

SEC source: 0001415889-24-020157 · form4-07262024_040704.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,348

F1 · shares: On July 24, 2024, the Reporting Person sold 15,134 shares of the Issuer's common stock on the open market at an average price of $77.79 per share.

SEC source: 0001415889-24-017143 · form4-06172024_040607.xml · derivative · entry 4

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,000

Underlying: Common Stock · 32,000 shares

Expires 2029-04-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On June 13, 2024, the Reporting Person exercised his stock option awarded on April 12, 2019 to purchase 32,000 shares of the Issuer's common stock at a price of $50.30 per share, by using the net settle method.

SEC source: 0001415889-24-017143 · form4-06172024_040607.xml · derivative · entry 3

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 32,000 shares

Expires 2028-04-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 13, 2024, the Reporting Person exercised his stock option awarded on April 13, 2018 to purchase 32,000 shares of the Issuer's common stock at a price of $37.60 per share, by using the net settle method.

SEC source: 0001415889-24-017143 · form4-06172024_040607.xml · nonDerivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,482

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On June 13, 2024, the Reporting Person exercised his stock option awarded on April 12, 2019 to purchase 32,000 shares of the Issuer's common stock at a price of $50.30 per share, by using the net settle method.

SEC source: 0001415889-24-017143 · form4-06172024_040607.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,360

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 13, 2024, the Reporting Person exercised his stock option awarded on April 13, 2018 to purchase 32,000 shares of the Issuer's common stock at a price of $37.60 per share, by using the net settle method.

SEC source: 0001415889-24-011141 · form4-04182024_090435.xml · derivative · entry 13

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,334

Underlying: Common Stock · 3,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSU awarded to the reporting person on April 18, 2022, 3,333 shares of the Common Stock became issuable to the Reporting Person on April 18, 2024.

F4 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSU awarded to the reporting person on April 18, 2022, 3,333 shares of the Common Stock became issuable to the Reporting Person on April 18, 2024.

SEC source: 0001415889-24-011141 · form4-04182024_090435.xml · nonDerivative · entry 4

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,348

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Pursuant to the three-year vesting schedule of the TRSU awarded to the reporting person on April 18, 2022, 3,333 shares of the Common Stock became issuable to the Reporting Person on April 18, 2024.

SEC source: 0001415889-24-011141 · form4-04182024_090435.xml · derivative · entry 12

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,000

Underlying: Common Stock · 30,000 shares

Expires 2026-06-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: On April 17, 2024, the Reporting Person exercised his option awarded on June 23, 2016 to purchase 30,000 shares of the Issuer's common stock at a price of $41.68 per share.

SEC source: 0001415889-24-011141 · form4-04182024_090435.xml · derivative · entry 11

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,667

Underlying: Common Stock · 4,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2024.

F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2024.

SEC source: 0001415889-24-011141 · form4-04182024_090435.xml · nonDerivative · entry 3

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,419

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: On April 17, 2024, the Reporting Person exercised his option awarded on June 23, 2016 to purchase 30,000 shares of the Issuer's common stock at a price of $41.68 per share.

SEC source: 0001415889-24-011141 · form4-04182024_090435.xml · nonDerivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,052

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2024.

SEC source: 0001415889-24-011141 · form4-04182024_090435.xml · derivative · entry 10

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 8,000 shares

Expires not disclosed

F9 · derivative.exercise_date: On April 16, 2024, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 8,000 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2025, 2026 and 2027 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2022, 2023 and 2024. The pay-out ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

F9 · derivative.expiration_date: On April 16, 2024, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 8,000 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2025, 2026 and 2027 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2022, 2023 and 2024. The pay-out ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

SEC source: 0001415889-24-011141 · form4-04182024_090435.xml · derivative · entry 9

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,667

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F8 · derivative.exercise_date: On April 16, 2024 the Reporting Person was granted TRSUs covering 10,000 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/16/2025.

F8 · derivative.expiration_date: On April 16, 2024 the Reporting Person was granted TRSUs covering 10,000 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/16/2025.

SEC source: 0001415889-24-011141 · form4-04182024_090435.xml · derivative · entry 8

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F7 · derivative.exercise_date: PBRSUs awarded on 4/16/2021 were forfeited due to failure to achieve the required TSR ranking.

F7 · derivative.expiration_date: PBRSUs awarded on 4/16/2021 were forfeited due to failure to achieve the required TSR ranking.

SEC source: 0001415889-24-011141 · form4-04182024_090435.xml · derivative · entry 7

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,000

Underlying: Common Stock · 4,000 shares

Expires not disclosed

F6 · derivative.exercise_date: On April 16, 2024, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 4,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2024 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F6 · derivative.expiration_date: On April 16, 2024, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 4,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2024 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

SEC source: 0001415889-24-011141 · form4-04182024_090435.xml · derivative · entry 6

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,000

Underlying: Common Stock · 3,000 shares

Expires 2034-04-16

F5 · shares: On April 16, 2024 the Reporting Person received 10-year options to purchase 3,000 shares of the Issuer's common stock with an exercise price of $61.22 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/16/2025.

SEC source: 0001415889-24-011141 · form4-04182024_090435.xml · derivative · entry 5

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,667

Underlying: Common Stock · 3,334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2021, 3,334 shares of Common Stock became issuable to the Reporting Person on April 16, 2024.

F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2021, 3,334 shares of Common Stock became issuable to the Reporting Person on April 16, 2024.

SEC source: 0001415889-24-011141 · form4-04182024_090435.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,799

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2021, 3,334 shares of Common Stock became issuable to the Reporting Person on April 16, 2024.

SEC source: 0001415889-23-014096 · form4-10112023_041001.xml · derivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,000

Underlying: Common Stock · 32,000 shares

Expires 2030-04-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On October 9, 2023, the Reporting Person exercised his option awarded on April 16, 2020 to purchase 32,000 shares of the Issuer's common stock at a price of $33.81 per share.

SEC source: 0001415889-23-014096 · form4-10112023_041001.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,824

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · derivative · entry 8

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,001

Underlying: Common Stock · 3,424 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 3,424 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 10,000 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

F2 · derivative.expiration_date: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 3,424 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 10,000 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

F10 · balance_after: As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes (a) 3,334 shares of TBRSUs granted on April 12, 2021; (b) 6,667 shares of TBRSUs granted on April 18, 2022; and (c) 12,000 shares of TBRSUs granted on April 17, 2023, all to vest pursuant to their respective three-year vesting schedules.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · nonDerivative · entry 2

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,824

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 3,424 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 10,000 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · derivative · entry 7

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F9 · derivative.exercise_date: On April 17, 2023, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 10,000 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2024, 2025 and 2026 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2021, 2022 and 2023. The pay-out ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievenent of the EPS ranking at the end of the three-year performance period. The awards will be more fully described in the Issuer's 2023 Proxy Statement. Each EPSRSU represents a contingent right to achieve one share of the Issuer's common stock.

F9 · derivative.expiration_date: On April 17, 2023, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 10,000 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2024, 2025 and 2026 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2021, 2022 and 2023. The pay-out ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievenent of the EPS ranking at the end of the three-year performance period. The awards will be more fully described in the Issuer's 2023 Proxy Statement. Each EPSRSU represents a contingent right to achieve one share of the Issuer's common stock.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · derivative · entry 6

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 5,000 shares

Expires not disclosed

F7 · derivative.exercise_date: On April 17, 2023, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 5,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2023 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F7 · derivative.expiration_date: On April 17, 2023, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 5,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2023 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F8 · balance_after: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 10,000 shares of PBRSUs granted on April 16, 2021; (b) a target number of 10,000 shares of PBRSUs granted on April 18, 2022; and (c) a target number of 5,000 shares of PBRSUs grated on April 17, 2023; all to vest in their entirety at the end of their respective three-year performance period.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · derivative · entry 5

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,334

Underlying: Common Stock · 12,000 shares

Expires not disclosed

F6 · derivative.exercise_date: On April 17, 2023, the Reporting Person was granted TBRSUs covering 12,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/17/2024.

F6 · derivative.expiration_date: On April 17, 2023, the Reporting Person was granted TBRSUs covering 12,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/17/2024.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · derivative · entry 4

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,000

Underlying: Common Stock · 5,000 shares

Expires 2033-04-17

F3 · shares: On April 17, 2023, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's common stock with an exercise price of $39.47 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/17/2024.

F4 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 30,000 shares of common stock at a price of $41.68 with Date Exercisable of 6/23/2017 and Expiration Date of 6/23/2026; (b) options to acquire 40,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 4/06/2018 and Expiration Date of 4/06/2027; (c) options to acquire 32,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 4/13/2019 and Expiration Date of 4/13/2028; (d) options to acquire 32,000 shares of common stock at a price of $50.30 with a Date Exercisable of 4/12/2020 and Expiration date of 4/12/2029;

F5 · balance_after: (e) options to acquire 32,000 shares of common stock at a price of $33.81 with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030; (f) options to acquire 10,000 shares of common stock at a price of $54.60 with a Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031; (g) options to acquire 10,000 shares of common stock at a price of $36.78 per share with Date Exercisable 4/18/2023 and Expiration Date of 4/18/2032; and (h) options to acquire 5,000 shares of common stock at a price of $39.47 per share with Date Exercisable of 4/17/2024 and Expiration Date of 4/17/2033; all subject to the three-year ratable vesting schedule described in footnote 3.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · derivative · entry 3

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,334

Underlying: Common Stock · 3,505 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 3,505 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 10,000 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

F1 · derivative.expiration_date: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 3,505 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 10,000 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

SEC source: 0001415889-23-006709 · form4-04192023_040404.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 3,505 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 10,000 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

SEC source: 0001415889-22-004131 · form4-04192022_040407.xml · derivative · entry 4

Watson David Hibbert · CIK 0001482442 · SVP AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F7 · derivative.exercise_date: On April 18, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 10,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/18/2023.

F7 · derivative.expiration_date: On April 18, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 10,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/18/2023.

F8 · balance_after: As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes (a) 6,667 shares of TBRSUs granted on April 12, 2021; and (b) 10,000 shares of TBRSUs granted on April 18, 2022, all to vest pursuant to the three year vesting schedule reported under footnote 7 above.

SEC source: 0001415889-22-004131 · form4-04192022_040407.xml · derivative · entry 3

Watson David Hibbert · CIK 0001482442 · SVP AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F5 · derivative.exercise_date: On April 18, 2022, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 10,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2022 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F5 · derivative.expiration_date: On April 18, 2022, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 10,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2022 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F6 · balance_after: As of the date of this filing, the total number of PBRSUs owned by the Reporting Person includes (a) a target number of 10,000 shares of PBRSUs granted on April 16, 2020; (b) a target number of 10,000 shares of PBRSUs granted on April 16, 2021, and (c) a target number of 10,000 shares of PBRSUs granted on April 18, 2022; all to vest in their entirety at the end of a three-year performance period as generally reported under footnote 5 above.

SEC source: 0001415889-22-004131 · form4-04192022_040407.xml · derivative · entry 2

Watson David Hibbert · CIK 0001482442 · SVP AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,000

Underlying: Common Stock · 10,000 shares

Expires 2032-04-18

F2 · shares: On April 18, 2022, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $36.78 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/18/2023.

F3 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 30,000 shares of common stock at a price of $41.68 with Date Exercisable of 06/23/2017 and Expiration Date of 06/23/2026; (b) options to acquire 40,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 32,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 32,000 shares of common stock at a price of $50.30 with a Date Exercisable of 4/12/2020 and Expiration date of 4/12/2029;

F4 · balance_after: (e) options to acquire 32,000 shares of common stock at a price of $33.81 with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030, (f) options to acquire 10,000 shares of common stock at a price of $54.60 with a Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031, and (g) options to acquire 10,000 shares of common stock at a price of $36.78 per share with Date Exercisable 4/18/2023 and Expiration Date of 4/18/2032; all subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001415889-22-004131 · form4-04192022_040407.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · SVP AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,895

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 16, 2022, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 3,411 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 10,000 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends.

SEC source: 0001415889-22-004063 · form4-04142022_040401.xml · derivative · entry 2

Watson David Hibbert · CIK 0001482442 · SVP AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 8,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 10,000 shares of PBRSUs granted on April 16, 2020 and (b) a target number of 10,000 shares of PBRSUs granted on April 16, 2021; all to vest in their entirety at the end of a three-year performance period.

F3 · derivative.expiration_date: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 10,000 shares of PBRSUs granted on April 16, 2020 and (b) a target number of 10,000 shares of PBRSUs granted on April 16, 2021; all to vest in their entirety at the end of a three-year performance period.

F3 · balance_after: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 10,000 shares of PBRSUs granted on April 16, 2020 and (b) a target number of 10,000 shares of PBRSUs granted on April 16, 2021; all to vest in their entirety at the end of a three-year performance period.

SEC source: 0001415889-22-004063 · form4-04142022_040401.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · SVP AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,484

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 12, 2022, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 8,984 shares of Common Stock. These PBRSUs, which were granted April 12, 2019 with a target number of 8,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2019 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 100% of the Target plus an adjustment for cash dividends.

F2 · balance_after: Assuming the trading window opens shortly after the year end financials are released or later this year, the Reporting Person intends to sell a portion of these shares primarily for the purposes of paying taxes related to the vesting of these shares.

SEC source: 0001104659-21-052670 · tm2113525-5_4seq1.xml · nonDerivative · entry 2

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

F2 · shares: On April 20, 2021, the Reporting Person sold 12,248 shares of the Issuer's common stock on the open market at an average price of $52.69 per share.

SEC source: 0001104659-21-052670 · tm2113525-5_4seq1.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,748

F1 · shares: On April 19, 2021, the Reporting Person sold 939 shares of the Issuer's common stock on the open market at an average price of $54.18 per share. As disclosed in the Reporting Person's Form 4 filed on April 13, 2021, the primary purpose for selling these shares (and those associated with footnote 2) related to the payment of taxes associated with the vesting of shares on April 9, 2021.

SEC source: 0001104659-21-052670 · tm2113525-5_4seq1.xml · derivative · entry 5

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F8 · shares: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 10,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

F8 · derivative.exercise_date: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 10,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

F8 · derivative.expiration_date: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 10,000 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022.

SEC source: 0001104659-21-052670 · tm2113525-5_4seq1.xml · derivative · entry 4

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F6 · shares: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 10,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F6 · derivative.exercise_date: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 10,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F6 · derivative.expiration_date: On April 16, 2021, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 10,000 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2021 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.

F7 · balance_after: As of the date of this filing, the total number of PBRSUs owned by the Reporting Person includes (a) a target number of 8,000 shares of PBRSUs granted on April 12, 2019; (b) a target number of 10,000 shares of PBRSUs granted on April 16, 2020; and (c) a target number of 10,000 shares of PBRSUs granted on April 16, 2021, all to vest in their entirety at the end of a three-year performance period as generally reported under footnote 6 above.

SEC source: 0001104659-21-052670 · tm2113525-5_4seq1.xml · derivative · entry 3

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,000

Underlying: Common Stock · 10,000 shares

Expires 2031-04-16

F3 · shares: On April 16, 2021, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $54.60 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/16/2022.

F4 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 30,000 shares of common stock at a price of $41.68 with Date Exercisable of 06/23/2017 and Expiration Date of 06/23/2026; (b) options to acquire 40,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 32,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 32,000 shares of common stock at a price of $50.30 with a Date Exercisable of 4/12/2020 and Expiration date of 4/12/2029;

F5 · balance_after: and (e) options to acquire 32,000 shares of common stock at a price of $33.81 with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030, and (f) options to acquire 10,000 shares of common stock at a price of $54.60 with a Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031, all subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001104659-21-049838 · tm2112892-2_4seq1.xml · derivative · entry 2

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 8,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 9, 2021, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 17,987 shares of Common Stock. These PBRSUs, which were granted April 10, 2018 with a target number of 8,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 200% of the Target plus an adjustment for cash dividends.

F1 · derivative.exercise_date: On April 9, 2021, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 17,987 shares of Common Stock. These PBRSUs, which were granted April 10, 2018 with a target number of 8,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 200% of the Target plus an adjustment for cash dividends.

F1 · derivative.expiration_date: On April 9, 2021, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 17,987 shares of Common Stock. These PBRSUs, which were granted April 10, 2018 with a target number of 8,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 200% of the Target plus an adjustment for cash dividends.

F3 · balance_after: As of the date of this filing, the remaining number of PBRSUs beneficially owned by the Reporting Person includes (a) a target number of 8,000 shares of PBRSUs granted on April 12, 2019 and; (b) a target number of 10,000 shares of PBRSUs granted on April 16, 2020, all to vest in their entirety at the end of a three-year performance period.

SEC source: 0001104659-21-049838 · tm2112892-2_4seq1.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,687

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 9, 2021, the Reporting Person had Performance-Based Restricted Stock Units (the "PBRSUs") vest in the amount of 17,987 shares of Common Stock. These PBRSUs, which were granted April 10, 2018 with a target number of 8,000 shares (the "Target"), had vesting subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The potential payout ratio of the Target, ranged from 0% to 200%, depending on the degree of achievement of the percentile of the TSR. The performance achievement over the measurement period resulted in the vesting of 200% of the Target plus an adjustment for cash dividends.

F2 · balance_after: Assuming the trading window opens shortly after the year end financials are released, the Reporting Person intends to sell a portion of these shares primarily for the purposes of paying taxes related to the vesting of these shares.

SEC source: 0001104659-20-048744 · a4.xml · derivative · entry 3

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F4 · shares: On April 16, 2020, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 10,000 shares (the "Target"), the vesting of which is subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies to be disclosed in the Issuer's 2020 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the percentile of the TSR.

F5 · derivative.exercise_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 4 above.

F5 · derivative.expiration_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 4 above.

F6 · balance_after: As of the date of this filing, the total number of PBRSUs owned by the Reporting Person includes (a) a target number of 8,000 shares of PBRSUs granted on April 13, 2018; (b) a target number of 8,000 shares of PBRSUs granted on April 12, 2019 and; (c) a target number of 10,000 shares of PBRSUs granted on April 16, 2020, all to vest in their entirety at the end of a three-year performance period as reported under footnote 4 above.

SEC source: 0001104659-20-048744 · a4.xml · derivative · entry 2

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,000

Underlying: Common Stock · 32,000 shares

Expires 2030-04-16

F1 · shares: On April 16, 2020, the Reporting Person received 10-year options to purchase 32,000 shares of the Issuer's common stock with an exercise price of $33.81 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/16/2021.

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 30,000 shares of common stock at a price of $41.68 with Date Exercisable of 06/23/2017 and Expiration Date of 06/23/2026; (b) options to acquire 40,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 32,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 32,000 shares of common stock at a price of $50.30 with a Date Exercisable of 4/12/2020 and Expiration date of 4/12/2029;

F3 · balance_after: and (e) options to acquire 32,000 shares of common stock at a price of $33.81 with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030, all subject to the aforementioned three-year ratably vesting schedule.

SEC source: 0001104659-19-073480 · a4.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,700